Markus P M, Selvaggi G, Cai X, Fung J J, Starzl T E
Department of Surgery, University of Düsseldorf, Germany.
Cell Transplant. 1993 Jul-Aug;2(4):345-53. doi: 10.1177/096368979300200418.
Mixed allogeneic chimerism (A + B-->A) was induced in rats by reconstitution of lethally irradiated LEW recipients with a mixture of T-cell depleted (TCD) syngeneic and TCD allogeneic ACI bone marrow. Thirty-seven percent of animals repopulated as stable mixed lymphopoietic chimeras, while the remainder had no detectable allogeneic chimerism. When evaluated for evidence of donor-specific transplantation tolerance, only those recipients with detectable allogeneic lymphoid chimerism exhibited acceptance of donor-specific skin and cardiac allografts. Despite transplantation over a major histocompatibility complex (MHC)- and minor-disparate barrier, animals accepted donor-specific ACI skin and primarily vascularized cardiac allografts permanently, while rejecting third party Brown Norway (BN) grafts. The tolerance induced was also donor-specific in vitro as evidenced by specific hyporeactivity to the allogeneic donor lymphoid elements, yet normal reactivity to MHC-disparate third party rat lymphoid cells. This model for mixed chimerism in the rat will be advantageous to investigate specific transplantation tolerance to primarily vascularized solid organ grafts that can be performed with relative ease in the rat, but not in the mouse, and may provide a method to study the potential existence of organ- or tissue-specific alloantigens in primarily vascularized solid organ allografts.
通过用T细胞去除(TCD)的同基因和TCD异基因ACI骨髓混合物重建经致死性照射的LEW受体,在大鼠中诱导了混合异基因嵌合体(A + B→A)。37%的动物重新填充为稳定的混合淋巴细胞嵌合体,而其余动物则没有可检测到的异基因嵌合体。在评估供体特异性移植耐受性的证据时,只有那些具有可检测到的异基因淋巴细胞嵌合体的受体表现出对供体特异性皮肤和心脏同种异体移植物的接受。尽管移植跨越了主要组织相容性复合体(MHC)和次要差异屏障,但动物永久性地接受了供体特异性ACI皮肤和主要血管化的心脏同种异体移植物,同时排斥第三方棕色挪威(BN)移植物。诱导的耐受性在体外也是供体特异性的,表现为对异基因供体淋巴细胞成分的特异性低反应性,但对MHC不同的第三方大鼠淋巴细胞具有正常反应性。大鼠中的这种混合嵌合体模型将有利于研究对主要血管化实体器官移植物的特异性移植耐受性,这种耐受性在大鼠中相对容易实现,但在小鼠中则不然,并且可能提供一种方法来研究主要血管化实体器官同种异体移植物中器官或组织特异性同种异体抗原的潜在存在。